BACKGROUND. Chronic liver disease develops in more than half of patients with post-transfusion hepatitis C, but little is known about the natural history of community-acquired hepatitis C. METHODS. In 1985 and 1986 we identified adults with acute non-A, non-B hepatitis in four counties in the United States and followed them prospectively. We used three markers to detect hepatitis C virus (HCV) infection in stored samples of serum: antibody to HCV (anti-HCV) detected by second-generation serologic assays; HCV RNA detected by polymerase-chain-reaction assay; and antibody to HCV antigen (anti-HCVAg) detected by fluorescent-antibody-blocking assay. RESULTS. Of 130 patients with non-A, non-B hepatitis, 106 (82 percent) had HCV infection, 93 were positive for anti-HCV, and 13 were positive only for HCV RNA or anti-HCVAg. Chronic hepatitis developed in 60 (62 percent) of 97 HCV-infected patients followed for 9 to 48 months, with no relation to the risk factors for infection. Ten of the 30 patients who had liver biopsies had chronic active hepatitis. In samples collected 42 to 48 months after the onset of hepatitis, HCV RNA was detected in 12 of 13 tested patients with chronic hepatitis and in all 15 tested patients with hepatitis that had resolved. Anti-HCV persisted in all but two of the initially positive patients, for a rate of antibody loss of 0.6 per 100 person-years. CONCLUSIONS. Patients with community-acquired hepatitis C have a high rate of chronic hepatitis. HCV may be a major cause of chronic liver disease in the United States, and in most patients HCV infection seems to persist for at least several years, even in the absence of active liver disease.
Source Information
Hepatitis Branch, Centers for Disease Control, Atlanta, GA 30333.
This article has been cited by other articles:
Deuffic-Burban, S., Mathurin, P., Valleron, A.-J.
(2009). Modelling the past, current and future HCV burden in France: detailed analysis and perspectives. Stat Methods Med Res
18: 233-252
[Abstract]
Wiegand, J., Deterding, K., Cornberg, M., Wedemeyer, H.
(2008). Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon {alpha}. J Antimicrob Chemother
62: 860-865
[Abstract][Full Text]
Guiltinan, A. M., Kaidarova, Z., Custer, B., Orland, J., Strollo, A., Cyrus, S., Busch, M. P., Murphy, E. L.
(2008). Increased All-Cause, Liver, and Cardiac Mortality among Hepatitis C Virus-seropositive Blood Donors. Am J Epidemiol
167: 743-750
[Abstract][Full Text]
Hsieh, M-Y, Dai, C-Y, Lee, L-P, Huang, J-F, Tsai, W-C, Hou, N-J, Lin, Z-Y, Chen, S-C, Wang, L-Y, Chang, W-Y, Chuang, W-L, Yu, M-L
(2008). Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C. J. Clin. Pathol.
61: 333-337
[Abstract][Full Text]
Kuiken, C., Hraber, P., Thurmond, J., Yusim, K.
(2008). The hepatitis C sequence database in Los Alamos. Nucleic Acids Res
36: D512-D516
[Abstract][Full Text]
Highbarger, H. C., Hu, Z., Kottilil, S., Metcalf, J. A., Polis, M. A., Vasudevachari, M. B., Lane, H. C., Dewar, R. L.
(2007). Comparison of the Abbott 7000 and Bayer 340 Systems for Measurement of Hepatitis C Virus Load. J. Clin. Microbiol.
45: 2808-2812
[Abstract][Full Text]
Radziewicz, H., Ibegbu, C. C., Fernandez, M. L., Workowski, K. A., Obideen, K., Wehbi, M., Hanson, H. L., Steinberg, J. P., Masopust, D., Wherry, E. J., Altman, J. D., Rouse, B. T., Freeman, G. J., Ahmed, R., Grakoui, A.
(2007). Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression. J. Virol.
81: 2545-2553
[Abstract][Full Text]
Scott, J. D., Gretch, D. R.
(2007). Molecular Diagnostics of Hepatitis C Virus Infection: A Systematic Review. JAMA
297: 724-732
[Abstract][Full Text]
Brown, R. J. P., Tarr, A. W., McClure, C. P., Juttla, V. S., Tagiuri, N., Irving, W. L., Ball, J. K.
(2007). Cross-genotype characterization of genetic diversity and molecular adaptation in hepatitis C virus envelope glycoprotein genes. J. Gen. Virol.
88: 458-469
[Abstract][Full Text]
Dahari, H., Ribeiro, R. M., Rice, C. M., Perelson, A. S.
(2007). Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 Cells. J. Virol.
81: 750-760
[Abstract][Full Text]
Kapadia, S. B., Barth, H., Baumert, T., McKeating, J. A., Chisari, F. V.
(2007). Initiation of Hepatitis C Virus Infection Is Dependent on Cholesterol and Cooperativity between CD81 and Scavenger Receptor B Type I. J. Virol.
81: 374-383
[Abstract][Full Text]
Issaragrisil, S., Kaufman, D. W., Anderson, T., Chansung, K., Leaverton, P. E., Shapiro, S., Young, N. S.
(2006). The epidemiology of aplastic anemia in Thailand. Blood
107: 1299-1307
[Abstract][Full Text]
McNelis, K.
(2006). Management of Hepatitis C Infection in the HIV-Infected Patient. Journal of Pharmacy Practice
19: 37-52
[Abstract]
Lee, S. H., Kim, Y. K., Kim, C. S., Seol, S. K., Kim, J., Cho, S., Song, Y. L., Bartenschlager, R., Jang, S. K.
(2005). E2 of Hepatitis C Virus Inhibits Apoptosis. J. Immunol.
175: 8226-8235
[Abstract][Full Text]
Gee, I, Alexander, G
(2005). Liver transplantation for hepatitis C virus related liver disease. Postgrad. Med. J.
81: 765-771
[Abstract][Full Text]
Moorman, J., Saad, M., Kosseifi, S., Krishnaswamy, G.
(2005). Hepatitis C Virus and the Lung: Implications for Therapy. Chest
128: 2882-2892
[Abstract][Full Text]
Owsianka, A., Tarr, A. W., Juttla, V. S., Lavillette, D., Bartosch, B., Cosset, F.-L., Ball, J. K., Patel, A. H.
(2005). Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein. J. Virol.
79: 11095-11104
[Abstract][Full Text]
Brown, R. J. P., Juttla, V. S., Tarr, A. W., Finnis, R., Irving, W. L., Hemsley, S., Flower, D. R., Borrow, P., Ball, J. K.
(2005). Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection. J. Gen. Virol.
86: 1931-1942
[Abstract][Full Text]
Joo, M., Hahn, Y. S., Kwon, M., Sadikot, R. T., Blackwell, T. S., Christman, J. W.
(2005). Hepatitis C Virus Core Protein Suppresses NF-{kappa}B Activation and Cyclooxygenase-2 Expression by Direct Interaction with I{kappa}B Kinase {beta}. J. Virol.
79: 7648-7657
[Abstract][Full Text]
Zhang, J., Yamada, O., Sakamoto, T., Yoshida, H., Araki, H., Shimotohno, K.
(2005). Exploiting cis-Acting Replication Elements To Direct Hepatitis C Virus-Dependent Transgene Expression. J. Virol.
79: 5923-5932
[Abstract][Full Text]
Yovtcheva, S. P., Rifai, M. A., Moles, J. K., Van Der Linden, B. J.
(2005). Psychiatric Comorbidity Among Hepatitis C-Positive Patients. Focus
3: 261-265
[Abstract][Full Text]
Kapadia, S. B., Chisari, F. V.
(2005). Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc. Natl. Acad. Sci. USA
102: 2561-2566
[Abstract][Full Text]
Kuiken, C., Yusim, K., Boykin, L., Richardson, R.
(2005). The Los Alamos hepatitis C sequence database. Bioinformatics
21: 379-384
[Abstract][Full Text]
Magder, L. S, Fix, A. D, Mikhail, N. N., Mohamed, M. K, Abdel-Hamid, M., Abdel-Aziz, F., Medhat, A., Strickland, G T.
(2005). Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence data. Int J Epidemiol
34: 160-165
[Abstract][Full Text]
Li, Y., Zhang, T., Ho, C., Orange, J. S., Douglas, S. D., Ho, W.-Z.
(2004). Natural killer cells inhibit hepatitis C virus expression. J. Leukoc. Biol.
76: 1171-1179
[Abstract][Full Text]
Spada, E, Mele, A, Berton, A, Ruggeri, L, Ferrigno, L, Garbuglia, A R, Perrone, M P, Girelli, G, Del Porto, P, Piccolella, E, Mondelli, M U, Amoroso, P, Cortese, R, Nicosia, A, Vitelli, A, Folgori, A, on behalf of the Acute Hepatitis C Italian Study G,
(2004). Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance. Gut
53: 1673-1681
[Abstract][Full Text]
Liu, Z., Netski, D. M., Mao, Q., Laeyendecker, O., Ticehurst, J. R., Wang, X.-H., Thomas, D. L., Ray, S. C.
(2004). Accurate Representation of the Hepatitis C Virus Quasispecies in 5.2-Kilobase Amplicons. J. Clin. Microbiol.
42: 4223-4229
[Abstract][Full Text]
Matsui, M., Moriya, O., Belladonna, M. L., Kamiya, S., Lemonnier, F. A., Yoshimoto, T., Akatsuka, T.
(2004). Adjuvant Activities of Novel Cytokines, Interleukin-23 (IL-23) and IL-27, for Induction of Hepatitis C Virus-Specific Cytotoxic T Lymphocytes in HLA-A*0201 Transgenic Mice. J. Virol.
78: 9093-9104
[Abstract][Full Text]
Forton, D. M., Karayiannis, P., Mahmud, N., Taylor-Robinson, S. D., Thomas, H. C.
(2004). Identification of Unique Hepatitis C Virus Quasispecies in the Central Nervous System and Comparative Analysis of Internal Translational Efficiency of Brain, Liver, and Serum Variants. J. Virol.
78: 5170-5183
[Abstract][Full Text]
Krantz, M. J., Mehler, P. S.
(2004). Treating Opioid Dependence: Growing Implications for Primary Care. Arch Intern Med
164: 277-288
[Abstract][Full Text]
Alfonso, V., Flichman, D. M., Sookoian, S., Mbayed, V. A., Campos, R. H.
(2004). Evolutionary study of HVR1 of E2 in chronic hepatitis C virus infection. J. Gen. Virol.
85: 39-46
[Abstract][Full Text]
Li, Y., Zhang, T., Douglas, S. D., Lai, J.-P., Xiao, W.-D., Pleasure, D. E., Ho, W.-Z.
(2003). Morphine Enhances Hepatitis C Virus (HCV) Replicon Expression. Am. J. Pathol.
163: 1167-1175
[Abstract][Full Text]
Cividini, A., Cerino, A., Muzzi, A., Furione, M., Rebucci, C., Segagni, L., Gatti, M., Barnaba, V., Mondelli, M. U.
(2003). Kinetics and Significance of Serum Hepatitis C Virus Core Antigen in Patients with Acute Hepatitis C. J. Clin. Microbiol.
41: 2144-2146
[Abstract][Full Text]
Kapadia, S. B., Brideau-Andersen, A., Chisari, F. V.
(2003). Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc. Natl. Acad. Sci. USA
100: 2014-2018
[Abstract][Full Text]
Sulkowski, M. S., Thomas, D. L.
(2003). Hepatitis C in the HIV-Infected Person. ANN INTERN MED
138: 197-207
[Abstract][Full Text]
Pancholi, P., Perkus, M., Tricoche, N., Liu, Q., Prince, A. M.
(2002). DNA Immunization with Hepatitis C Virus (HCV) Polycistronic Genes or Immunization by HCV DNA Priming-Recombinant Canarypox Virus Boosting Induces Immune Responses and Protection from Recombinant HCV-Vaccinia Virus Infection in HLA-A2.1-Transgenic Mice. J. Virol.
77: 382-390
[Abstract][Full Text]
Brown, J L
(2002). HCV infection should be managed in specialist centres. Gut
51: 626-627
[Full Text]
Salomon, J. A., Weinstein, M. C., Hammitt, J. K., Goldie, S. J.
(2002). Empirically Calibrated Model of Hepatitis C Virus Infection in the United States. Am J Epidemiol
156: 761-773
[Abstract][Full Text]
Burioni, R., Matsuura, Y., Mancini, N., Tani, H., Miyamura, T., Varaldo, P. E., Clementi, M.
(2002). Diverging Effects of Human Recombinant Anti-Hepatitis C Virus (HCV) Antibody Fragments Derived from a Single Patient on the Infectivity of a Vesicular Stomatitis Virus/HCV Pseudotype. J. Virol.
76: 11775-11779
[Abstract][Full Text]
Sarrazin, C., Herrmann, E., Bruch, K., Zeuzem, S.
(2002). Hepatitis C Virus Nonstructural 5A Protein and Interferon Resistance: a New Model for Testing the Reliability of Mutational Analyses. J. Virol.
76: 11079-11090
[Abstract][Full Text]
Chu, C-M, Yeh, C T, Sheen, I S, Liaw, Y F
(2002). Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV. Gut
51: 95-99
[Abstract][Full Text]
Major, M. E., Mihalik, K., Puig, M., Rehermann, B., Nascimbeni, M., Rice, C. M., Feinstone, S. M.
(2002). Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge. J. Virol.
76: 6586-6595
[Abstract][Full Text]
Trimoulet, P., Halfon, P., Pohier, E., Khiri, H., Chene, G., Fleury, H.
(2002). Evaluation of the VERSANT HCV RNA 3.0 Assay for Quantification of Hepatitis C Virus RNA in Serum. J. Clin. Microbiol.
40: 2031-2036
[Abstract][Full Text]
Kondili, L A, Chionne, P, Costantino, A, Villano, U, Lo Noce, C, Pannozzo, F, Mele, A, Giampaoli, S, Rapicetta, M
(2002). Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut
50: 693-696
[Abstract][Full Text]
(2002). Diagnosis and Management of the HCV/HIV-Coinfected Patient. AIDS Clin Care
2002: 1-1
[Full Text]
Patel, R., Germer, J. J., Tocci, G., Visco-Comandini, U., Antonucci, G., Muir, A. J., Rockey, D. C., Seligman, H. K., Fox, R. K., Cornberg, M., Jaeckel, E., Manns, M. P.
(2002). Treatment of Acute Hepatitis C with Interferon Alfa-2b. NEJM
346: 1091-1092
[Full Text]
Page-Shafer, K. A., Cahoon-Young, B., Klausner, J. D., Morrow, S., Molitor, F., Ruiz, J., McFarland, W.
(2002). Hepatitis C Virus Infection in Young, Low-Income Women: The Role of Sexually Transmitted Infection as a Potential Cofactor for HCV Infection. AJPH
92: 670-676
[Abstract][Full Text]
Shirota, Y., Luo, H., Qin, W., Kaneko, S., Yamashita, T., Kobayashi, K., Murakami, S.
(2002). Hepatitis C Virus (HCV) NS5A Binds RNA-dependent RNA Polymerase (RdRP) NS5B and Modulates RNA-dependent RNA Polymerase Activity. J. Biol. Chem.
277: 11149-11155
[Abstract][Full Text]
Ikeda, M., Yi, M., Li, K., Lemon, S. M.
(2002). Selectable Subgenomic and Genome-Length Dicistronic RNAs Derived from an Infectious Molecular Clone of the HCV-N Strain of Hepatitis C Virus Replicate Efficiently in Cultured Huh7 Cells. J. Virol.
76: 2997-3006
[Abstract][Full Text]
Yenigun, A., Durupinar, B.
(2002). Decreased Frequency of the HLA-DRB1*11 Allele in Patients with Chronic Hepatitis C Virus Infection. J. Virol.
76: 1787-1789
[Abstract][Full Text]
Radkowski, M., Wilkinson, J., Nowicki, M., Adair, D., Vargas, H., Ingui, C., Rakela, J., Laskus, T.
(2002). Search for Hepatitis C Virus Negative-Strand RNA Sequences and Analysis of Viral Sequences in the Central Nervous System: Evidence of Replication. J. Virol.
76: 600-608
[Abstract][Full Text]
Curran, R., Jameson, C. L., Craggs, J. K., Grabowska, A. M., Thomson, B. J., Robins, A., Irving, W. L., Ball, J. K.
(2002). Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver disease severity. J. Gen. Virol.
83: 11-23
[Abstract][Full Text]
Thimme, R., Oldach, D., Chang, K.-M., Steiger, C., Ray, S. C., Chisari, F. V.
(2001). Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection. JEM
194: 1395-1406
[Abstract][Full Text]
Gerotto, M., Dal Pero, F., Loffreda, S., Bianchi, F. B., Alberti, A., Lenzi, M.
(2001). A 385 insertion in the hypervariable region 1 of hepatitis C virus E2 envelope protein is found in some patients with mixed cryoglobulinemia type 2. Blood
98: 2657-2663
[Abstract][Full Text]
Bugli, F., Mancini, N., Kang, C.-Y., Di Campli, C., Grieco, A., Manzin, A., Gabrielli, A., Gasbarrini, A., Fadda, G., Varaldo, P. E., Clementi, M., Burioni, R.
(2001). Mapping B-Cell Epitopes of Hepatitis C Virus E2 Glycoprotein Using Human Monoclonal Antibodies from Phage Display Libraries. J. Virol.
75: 9986-9990
[Abstract][Full Text]
Yovtcheva, S. P., Rifai, M. A., Moles, J. K., Van Der Linden, B. J.
(2001). Psychiatric Comorbidity Among Hepatitis C-Positive Patients. Psychosomatics
42: 411-415
[Abstract][Full Text]
Sarrazin, C., Hendricks, D. A., Sedarati, F., Zeuzem, S.
(2001). Assessment, by Transcription-Mediated Amplification, of Virologic Response in Patients with Chronic Hepatitis C Virus Treated with Peginterferon {alpha}-2a. J. Clin. Microbiol.
39: 2850-2855
[Abstract][Full Text]
Walsh, K, Alexander, G J M
(2001). Update on chronic viral hepatitis. Postgrad. Med. J.
77: 498-505
[Abstract][Full Text]
Lauer, G. M., Walker, B. D.
(2001). Hepatitis C Virus Infection. NEJM
345: 41-52
[Full Text]
Booth, J C L, O'Grady, J, Neuberger, J
(2001). Clinical guidelines on the management of hepatitis C. Gut
49: I1-21
[Full Text]
Auffermann-Gretzinger, S., Keeffe, E. B., Levy, S.
(2001). Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood
97: 3171-3176
[Abstract][Full Text]
Mohsen, A H, Group, T. H. S.
(2001). The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut
48: 707-713
[Abstract][Full Text]
Lu, L., Nakano, T., Orito, E., Mizokami, M., Robertson, B. H.
(2001). Evaluation of Accumulation of Hepatitis C Virus Mutations in a Chronically Infected Chimpanzee: Comparison of the Core, E1, HVR1, and NS5b Regions. J. Virol.
75: 3004-3009
[Abstract][Full Text]
Laskus, T., Wang, L.-F., Radkowski, M., Vargas, H., Nowicki, M., Wilkinson, J., Rakela, J.
(2001). Exposure of Hepatitis C Virus (HCV) RNA-Positive Recipients to HCV RNA-Positive Blood Donors Results in Rapid Predominance of a Single Donor Strain and Exclusion and/or Suppression of the Recipient Strain. J. Virol.
75: 2059-2066
[Abstract][Full Text]
Jacobson, J. M., Feinman, L., Liebes, L., Ostrow, N., Koslowski, V., Tobia, A., Cabana, B. E., Lee, D.-H., Spritzler, J., Prince, A. M.
(2001). Pharmacokinetics, Safety, and Antiviral Effects of Hypericin, a Derivative of St. John's Wort Plant, in Patients with Chronic Hepatitis C Virus Infection. Antimicrob. Agents Chemother.
45: 517-524
[Abstract][Full Text]
Dufour, D. R., Lott, J. A., Nolte, F. S., Gretch, D. R., Koff, R. S., Seeff, L. B.
(2000). Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring. Clin. Chem.
46: 2050-2068
[Abstract][Full Text]
Mehta, S. H., Brancati, F. L., Sulkowski, M. S., Strathdee, S. A., Szklo, M., Thomas, D. L.
(2000). Prevalence of Type 2 Diabetes Mellitus among Persons with Hepatitis C Virus Infection in the United States. ANN INTERN MED
133: 592-599
[Abstract][Full Text]
Yu, M.-L., Chuang, W.-L., Dai, C.-Y., Chen, S.-C., Lin, Z.-Y., Hsieh, M.-Y., Wang, L.-Y., Chang, W.-Y.
(2000). Clinical Evaluation of the Automated COBAS AMPLICOR HCV MONITOR Test Version 2.0 for Quantifying Serum Hepatitis C Virus RNA and Comparison to the Quantiplex HCV Version 2.0 Test. J. Clin. Microbiol.
38: 2933-2939
[Abstract][Full Text]
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., Laeyendecker, O., Boitnott, J., Wilson, L. E., Vlahov, D.
(2000). The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors. JAMA
284: 450-456
[Abstract][Full Text]
Beltrami, E. M., Williams, I. T., Shapiro, C. N., Chamberland, M. E.
(2000). Risk and Management of Blood-Borne Infections in Health Care Workers. Clin. Microbiol. Rev.
13: 385-407
[Abstract][Full Text]
Degos, F, Christidis, C, Ganne-Carrie, N, Farmachidi, J-P, Degott, C, Guettier, C, Trinchet, J-C, Beaugrand, M, Chevret, S
(2000). Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut
47: 131-136
[Abstract][Full Text]
Manzin, A., Solforosi, L., Debiaggi, M., Zara, F., Tanzi, E., Romanò, L., Zanetti, A. R., Clementi, M.
(2000). Dominant Role of Host Selective Pressure in Driving Hepatitis C Virus Evolution in Perinatal Infection. J. Virol.
74: 4327-4334
[Abstract][Full Text]
Khudyakov, Y. E., Cong, M.-e., Nichols, B., Reed, D., Dou, X.-G., Viazov, S. O., Chang, J., Fried, M. W., Williams, I., Bower, W., Lambert, S., Purdy, M., Roggendorf, M., Fields, H. A.
(2000). Sequence Heterogeneity of TT Virus and Closely Related Viruses. J. Virol.
74: 2990-3000
[Abstract][Full Text]
Ray, S. C., Mao, Q., Lanford, R. E., Bassett, S., Laeyendecker, O., Wang, Y.-M., Thomas, D. L.
(2000). Hypervariable Region 1 Sequence Stability during Hepatitis C Virus Replication in Chimpanzees. J. Virol.
74: 3058-3066
[Abstract][Full Text]
SOMA, J., SAITO, T., TAGUMA, Y., CHIBA, S., SATO, H., SUGIMURA, K., OGAWA, S., ITO, S.
(2000). High Prevalence and Adverse Effect of Hepatitis C Virus Infection in Type II Diabetic-Related Nephropathy. J. Am. Soc. Nephrol.
11: 690-699
[Abstract][Full Text]
Schweyer, S, Mihm, S, Radzun, H J, Hartmann, H, Fayyazi, A
(2000). Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection. Gut
46: 255-259
[Abstract][Full Text]
McGuinness, P H, Painter, D, Davies, S, McCaughan, G W
(2000). Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut
46: 260-269
[Abstract][Full Text]
Lefrere, J.-J., Roudot-Thoraval, F., Lefrere, F., Kanfer, A., Mariotti, M., Lerable, J., Thauvin, M., Lefevre, G., Rouger, P., Girot, R.
(2000). Natural history of the TT virus infection through follow-up of TTV DNA-positive multiple-transfused patients. Blood
95: 347-351
[Abstract][Full Text]
Shimoike, T., Mimori, S., Tani, H., Matsuura, Y., Miyamura, T.
(1999). Interaction of Hepatitis C Virus Core Protein with Viral Sense RNA and Suppression of Its Translation. J. Virol.
73: 9718-9725
[Abstract][Full Text]
Heim, M. H., Moradpour, D., Blum, H. E.
(1999). Expression of Hepatitis C Virus Proteins Inhibits Signal Transduction through the Jak-STAT Pathway. J. Virol.
73: 8469-8475
[Abstract][Full Text]
Chu, C M, Yeh, C T, Liaw, Y F
(1999). Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus. Gut
45: 613-617
[Abstract][Full Text]
Gerotto, M., Sullivan, D. G., Polyak, S. J., Chemello, L., Cavalletto, L., Pontisso, P., Alberti, A., Gretch, D. R.
(1999). Effect of Retreatment with Interferon Alone or Interferon plus Ribavirin on Hepatitis C Virus Quasispecies Diversification in Nonresponder Patients with Chronic Hepatitis C. J. Virol.
73: 7241-7247
[Abstract][Full Text]
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., Margolis, H. S.
(1999). The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994. NEJM
341: 556-562
[Abstract][Full Text]
Cancre, N., Bois, F., Gresenguet, G., Fretz, C., Fournel, J.-J., Belec, L.
(1999). Screening Blood Donations for Hepatitis C in Central Africa: Analysis of a Risk- and Cost-based Decision Tree. Med Decis Making
19: 296-306
[Abstract]
Osella, A. R., Sonzogni, L., Cavallini, A., Foti, L., Guerra, V., Di Leo, A., Mondelli, M. U., Misciagna, G., Silini, E. M.
(1999). Molecular Epidemiology of Hepatitis C Virus Infection in an Area of Hyperendemicity in Southern Italy: a Population-Based Study. J. Clin. Microbiol.
37: 2371-2372
[Abstract][Full Text]
Honda, M., Rijnbrand, R., Abell, G., Kim, D., Lemon, S. M.
(1999). Natural Variation in Translational Activities of the 5' Nontranslated RNAs of Hepatitis C Virus Genotypes 1a and 1b: Evidence for a Long-Range RNA-RNA Interaction outside of the Internal Ribosomal Entry Site. J. Virol.
73: 4941-4951
[Abstract][Full Text]
Bellentani, S, Pozzato, G, Saccoccio, G, Crovatto, M, Croce, L S, Mazzoran, L, Masutti, F, Cristianini, G, Tiribelli, C
(1999). Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut
44: 874-880
[Abstract][Full Text]
Ray, S. C., Wang, Y.-M., Laeyendecker, O., Ticehurst, J. R., Villano, S. A., Thomas, D. L.
(1999). Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy. J. Virol.
73: 2938-2946
[Abstract][Full Text]
Major, M. E., Mihalik, K., Fernandez, J., Seidman, J., Kleiner, D., Kolykhalov, A. A., Rice, C. M., Feinstone, S. M.
(1999). Long-Term Follow-Up of Chimpanzees Inoculated with the First Infectious Clone for Hepatitis C Virus. J. Virol.
73: 3317-3325
[Abstract][Full Text]
Stapleton, J. T., Klinzman, D., Schmidt, W. N., Pfaller, M. A., Wu, P., LaBrecque, D. R., Han, J.-q., Phillips, M. J. P., Woolson, R., Alden, B.
(1999). Prospective Comparison of Whole-Blood- and Plasma-Based Hepatitis C Virus RNA Detection Systems: Improved Detection Using Whole Blood as the Source of Viral RNA. J. Clin. Microbiol.
37: 484-489
[Abstract][Full Text]
Cramp, M E, Carucci, P, Rossol, S, Chokshi, S, Maertens, G, Williams, R, Naoumov, N V
(1999). Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia. Gut
44: 424-429
[Abstract][Full Text]
Goodnough, L. T., Brecher, M. E., Kanter, M. H., AuBuchon, J. P.
(1999). Transfusion Medicine -- Blood Transfusion- First of Two Parts. NEJM
340: 438-447
[Full Text]
Bassett, S. E., Thomas, D. L., Brasky, K. M., Lanford, R. E.
(1999). Viral Persistence, Antibody to E1 and E2, and Hypervariable Region 1 Sequence Stability in Hepatitis C Virus-Inoculated Chimpanzees. J. Virol.
73: 1118-1126
[Abstract][Full Text]
Chang, K.-M., Gruener, N. H., Southwood, S., Sidney, J., Pape, G. R., Chisari, F. V., Sette, A.
(1999). Identification of HLA-A3 and -B7-Restricted CTL Response to Hepatitis C Virus in Patients with Acute and Chronic Hepatitis C. J. Immunol.
162: 1156-1164
[Abstract][Full Text]
Encke, J., zu Putlitz, J., Geissler, M., Wands, J. R.
(1998). Genetic Immunization Generates Cellular and Humoral Immune Responses Against the Nonstructural Proteins of the Hepatitis C Virus in a Murine Model. J. Immunol.
161: 4917-4923
[Abstract][Full Text]
Prati, D., Zanella, A., Farma, E., De Mattei, C., Bosoni, P., Zappa, M., Picone, A., Mozzi, F., Rebulla, P., Cappellini, M. D., Allain, J.-P., Sirchia, G.
(1998). A Multicenter Prospective Study on the Risk of Acquiring Liver Disease in Anti-Hepatitis C Virus Negative Patients Affected From Homozygous beta -Thalassemia. Blood
92: 3460-3464
[Abstract][Full Text]
Hsieh, T.-Y., Matsumoto, M., Chou, H.-C., Schneider, R., Hwang, S. B., Lee, A. S., Lai, M. M. C.
(1998). Hepatitis C Virus Core Protein Interacts with Heterogeneous Nuclear Ribonucleoprotein K. J. Biol. Chem.
273: 17651-17659
[Abstract][Full Text]
Previous
